Pawan Hari
Internal Medicine · Detroit, MINPI 1336376904
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Boston Scientific at 55.6% of the total. 2025 is the largest year on record at $2,501, more than ten times the $119 reported in 2019. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $166.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Edwards Lifesciences$837
- Philips North America LLC$631
- Abbott$311
- Shockwave Medical, Inc$48
- Medtronic$20
Across 4 payments — averaging $17,742 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$68K
- Amgen$3K
What the payments were for
- Consulting fees$2,18853%
- Travel & lodging$1,04025%
- Food & beverage$93022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $2,309 |
| Edwards Lifesciences | 5 | $837 |
| Philips North America LLC | 3 | $631 |
| Abbott | 10 | $311 |
| Shockwave Medical, Inc | 1 | $48 |
| Medtronic | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,157 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $137,858 |
| EntrestoSacubitril/Valsartan | 19 | $31,982 |
| Repatha SureclickEvolocumab | 15 | $10,687 |
| Metoprolol Succinate | 187 | $3,689 |
| Atorvastatin Calcium | 113 | $1,571 |
| Potassium Chloride | 22 | $1,086 |
| Amlodipine Besylate | 115 | $1,037 |
| Lisinopril | 55 | $691 |
| Losartan Potassium | 60 | $687 |
| Spironolactone | 84 | $682 |
| Flecainide Acetate | 17 | $512 |
| Furosemide | 73 | $502 |
| Rosuvastatin Calcium | 42 | $500 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $458 |
| Bisoprolol Fumarate | 11 | $402 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Detroit
- Saroj NeupaneDetroit$373K
- David StocktonDetroit$306K
- Mervin WolffDetroit$182K
- Philip KuriakoseDetroit$143K
- Ivan HansonDetroit$137K
- Omeralfaroug AdamDetroit$124K
- Jalal MaghfourDetroit$81K
- Ravish ParekhDetroit$68K
- Dipenkumar ModiDetroit$64K
- Garen WolffDetroit$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.